Clough Capital Partners’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Clough Capital Partners’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-328,351	Closed	-$12M	–	165
2018 Q1	$12M	Buy	+328,351	New	+$13.8M	1.15%	28

Clough Capital Partners's ARMO Position: Q2 2018 in Review

Clough Capital Partners sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 328,351 shares — an estimated $12M sold.

Clough Capital Partners first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $12M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Clough Capital Partners reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Clough Capital Partners sold 328,351 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $12M.
Clough Capital Partners first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Clough Capital Partners's ARMO BioSciences, Inc. Common Stock position peaked at $12M in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Clough Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.